Andrew Corin

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial

Jo Hardy, Christina Baggott, James Fingleton et al. · The Lancet · 2019 · 276 citations

Pharmacy, Internal Medicine, Pharmacotherapy +9

Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group, randomised controlled trial

Ian Pavord, Mark Holliday, Helen K. Reddel et al. · The Lancet Respiratory Medicine · 2020 · 116 citations · Full text

Life Sciences, Immunology, Internal Medicine +16

Metrics of salbutamol use as predictors of future adverse outcomes in asthma

Mitesh Patel, Janine Pilcher, Helen K. Reddel et al. · Clinical & Experimental Allergy · 2013 · 81 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17